• Something wrong with this record ?

Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death

Moserova I, Truxova I, Garg AD, Tomala J, Agostinis P, Cartron PF, Vosahlikova S, Kovar M, Spisek R, Fucikova J

. 2016 ; 6 (1) : e1258505.

Language English Country United States

Persistent link   https://www.medvik.cz/link/bmc19036789

Grant support
NT12402 MZ0 CEP Register

High hydrostatic pressure (HHP) promotes key characteristics of immunogenic cell death (ICD), in thus far resembling immunogenic chemotherapy and ionizing irradiation. Here, we demonstrate that cancer cells succumbing to HHP induce CD4+ and CD8+ T cell-dependent protective immunity in vivo. Moreover, we show that cell death induction by HHP relies on the overproduction of reactive oxygen species (ROS), causing rapid establishment of the integrated stress response, eIF2α phosphorylation by PERK, and sequential caspase-2, -8 and -3 activation. Non-phosphorylatable eIF2α, depletion of PERK, caspase-2 or -8 compromised calreticulin exposure by cancer cells succumbing to HHP but could not inhibit death. Interestingly, the phagocytosis of HHP-treated malignant cells by dendritic cells was suppressed by the knockdown of caspase-2 in the former. Thus, caspase-2 mediates a key function in the interaction between dying cancer cells and antigen presenting cells. Our results indicate that the ROS→PERK→eIF2α→caspase-2 signaling pathway is central for the perception of HHP-driven cell death as immunogenic.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19036789
003      
CZ-PrNML
005      
20200102144441.0
007      
ta
008      
191015s2016 xxu f 000 0|eng||
009      
AR
024    0_
$a 10.1080/2162402X.2016.1258505 $2 doi
035    __
$a (Pubmed)28197379
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Moserová, Irena $7 xx0140348 $u Sotio, Prague, Czech Republic; 2nd Medical Faculty and University Hospital Motol, Charles University, Prague, Czech Republic
245    10
$a Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death / $c Moserova I, Truxova I, Garg AD, Tomala J, Agostinis P, Cartron PF, Vosahlikova S, Kovar M, Spisek R, Fucikova J
520    9_
$a High hydrostatic pressure (HHP) promotes key characteristics of immunogenic cell death (ICD), in thus far resembling immunogenic chemotherapy and ionizing irradiation. Here, we demonstrate that cancer cells succumbing to HHP induce CD4+ and CD8+ T cell-dependent protective immunity in vivo. Moreover, we show that cell death induction by HHP relies on the overproduction of reactive oxygen species (ROS), causing rapid establishment of the integrated stress response, eIF2α phosphorylation by PERK, and sequential caspase-2, -8 and -3 activation. Non-phosphorylatable eIF2α, depletion of PERK, caspase-2 or -8 compromised calreticulin exposure by cancer cells succumbing to HHP but could not inhibit death. Interestingly, the phagocytosis of HHP-treated malignant cells by dendritic cells was suppressed by the knockdown of caspase-2 in the former. Thus, caspase-2 mediates a key function in the interaction between dying cancer cells and antigen presenting cells. Our results indicate that the ROS→PERK→eIF2α→caspase-2 signaling pathway is central for the perception of HHP-driven cell death as immunogenic.
650    12
$a kaspasy $7 D020169
650    _2
$a buněčná smrt $7 D016923
650    12
$a hydrostatický tlak $7 D006874
650    _2
$a reaktivní formy kyslíku $7 D017382
650    _2
$a nádorové buněčné linie $7 D045744
650    12
$a iniciační kaspasy $7 D053471
650    12
$a stres endoplazmatického retikula $7 D059865
650    12
$a kalretikulin $7 D037282
700    1_
$a Truxová, Iva $7 xx0238532 $u Sotio, Prague, Czech Republic; 2nd Medical Faculty and University Hospital Motol, Charles University, Prague, Czech Republic
700    1_
$a Garg AD $u Cell Death Research and Therapy Unit, Department of Cellular and Molecular Medicine, KU Leuven University of Leuven , Leuven, Belgium
700    1_
$a Tomala, Jakub, $d 1981- $7 xx0230748 $u Laboratory of Tumor Immunology, Institute of Microbiology, Academy of Sciences of the Czech Republic , Prague, Czech Republic
700    1_
$a Agostinis P $u Cell Death Research and Therapy Unit, Department of Cellular and Molecular Medicine, KU Leuven University of Leuven , Leuven, Belgium
700    1_
$a Cartron PF $u Centre de Recherche en Cancérologie Nantes-Angers, INSERM, U892 , Nantes, France
700    1_
$a Vošahlíková, Šárka, $d 1981- $7 xx0075828 $u Sotio , Prague, Czech Republic
700    1_
$a Kovář, Marek $7 xx0114168 $u Laboratory of Tumor Immunology, Institute of Microbiology, Academy of Sciences of the Czech Republic , Prague, Czech Republic
700    1_
$a Špíšek, Radek, $d 1975- $7 nlk20030145288 $u Sotio, Prague, Czech Republic; 2nd Medical Faculty and University Hospital Motol, Charles University, Prague, Czech Republic
700    1_
$a Fučíková, Jitka, $d 1983- $7 xx0116819 $u Sotio, Prague, Czech Republic; 2nd Medical Faculty and University Hospital Motol, Charles University, Prague, Czech Republic
773    0_
$t Oncoimmunology $x 2162-4011 $g Roč. 6, č. 1 (2016), s. e1258505 $w MED00190079
910    __
$a ABA008 $b sig $y p $z 0
990    __
$a 20191015115605 $b ABA008
991    __
$a 20200102144803 $b ABA008
999    __
$a ok $b bmc $g 1454947 $s 1075356
BAS    __
$a 3
BMC    __
$a 2016 $b 6 $c 1 $d e1258505 $x MED00190079 $i 2162-4011 $m Oncoimmunology
GRA    __
$a NT12402 $p MZ0
LZP    __
$a NLK 2019/lp

Find record

Citation metrics

Archiving options